Survival outcomes in a prospective randomized multicenter Phase III trial comparing patients undergoing anatomical segmentectomy versus standard lobectomy for non-small cell lung cancer up to 2 cm.
- DOI
- 10.1016/j.lungcan.2022.08.013
- Published
- 2022 Oct
- Container
- Lung cancer (Amsterdam, Netherlands)
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.lungcan.2022.08.013,
title = {Survival outcomes in a prospective randomized multicenter Phase III trial comparing patients undergoing anatomical segmentectomy versus standard lobectomy for non-small cell lung cancer up to 2 cm.},
author = {Stamatis G and Leschber G and Schwarz B and Brintrup DL and Flossdorf S and Passlick B and Hecker E and Kugler C and Eichhorn M and Krbek T and Eggeling S and Hatz R and Müller MR and Hillinger S and Aigner C and Jöckel KH},
year = {2022},
journal = {Lung cancer (Amsterdam, Netherlands)},
doi = {10.1016/j.lungcan.2022.08.013},
url = {https://doi.org/10.1016/j.lungcan.2022.08.013}
}RIS
TY - JOUR TI - Survival outcomes in a prospective randomized multicenter Phase III trial comparing patients undergoing anatomical segmentectomy versus standard lobectomy for non-small cell lung cancer up to 2 cm. AU - Stamatis G AU - Leschber G AU - Schwarz B AU - Brintrup DL AU - Flossdorf S AU - Passlick B AU - Hecker E AU - Kugler C AU - Eichhorn M AU - Krbek T AU - Eggeling S AU - Hatz R AU - Müller MR AU - Hillinger S AU - Aigner C AU - Jöckel KH PY - 2022 JO - Lung cancer (Amsterdam, Netherlands) DO - 10.1016/j.lungcan.2022.08.013 UR - https://doi.org/10.1016/j.lungcan.2022.08.013 ER -
APA
G, S., G, L., B, S., DL, B., S, F., B, P., E, H., C, K., M, E., T, K., S, E., R, H., MR, M., S, H., C, A., & KH, J. (2022). Survival outcomes in a prospective randomized multicenter Phase III trial comparing patients undergoing anatomical segmentectomy versus standard lobectomy for non-small cell lung cancer up to 2 cm.. Lung cancer (Amsterdam, Netherlands). https://doi.org/10.1016/j.lungcan.2022.08.013
Source records
- pubmed · retrieved 2026-09-27T08:50:10.148Z